Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder

Trial Profile

Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2013

At a glance

  • Drugs Imidafenacin (Primary) ; Fesoterodine
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors LG Life Sciences
  • Most Recent Events

    • 18 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top